Mounjaro's September Price Rise: How Much Did It Go Up To?

Step 1: understand what actually changed on 1 September 2025

Eli Lilly, the manufacturer of Mounjaro, adjusted its UK list prices with effect from 1 September 2025. The shift was substantial at the higher doses: as widely reported at the time, the 15mg pen's list price moved from approximately £122 to approximately £330 for a four-week supply. Lower doses rose by smaller amounts, but the direction was consistent across the range. These are Lilly's own list figures, private pharmacies and online clinics set their own retail prices on top of that base, which is why the market range since September sits at roughly £149 to £375 per month depending on the dose and the provider you choose.

It is worth being clear about what these numbers represent. They cover one pen, which delivers four once-weekly injections. The treatment schedule starts at 2.5mg and is titrated upward by your prescriber, typically in monthly steps, so the cost you see quoted for a starter dose is not the cost you would stay on indefinitely. To understand the longer picture, our page on what a full course of Mounjaro costs breaks that down properly.

If you're feeling unsettled by how much the September increase added to an already significant outlay, that reaction is completely understandable. Many people had built the pre-September price into their plans, and our page on how much Mounjaro will cost in September can help you work through what the revised figures mean for your budget. The rest of this page is intended to help you read those figures honestly.

Step 2: check what a quoted price actually covers

Once the September list-price change came in, some providers responded by absorbing part of the increase while others passed it through fully. The headline monthly figure you see advertised does not always include everything you need. Common extras that some services charge separately include the initial clinical consultation, the private prescription fee, and delivery. Some clinics also charge for follow-up reviews or dose-change approvals, which are not optional steps, they happen every time your treatment changes.

Aftercare matters more than it might seem. Mounjaro's titration schedule means your dose is reviewed and potentially increased several times during a course of treatment. Each of those reviews requires a clinician to look at your weight, your tolerance, and your clinical picture. If that review costs extra each time, the real monthly outlay can climb well above the headline pen price. Our Mounjaro pricing page sets out what a genuinely all-in price should include so you can compare like with like.

For a fuller picture of how prices have shifted and what different doses now typically cost, the detail is on our Mounjaro September prices page. The context behind the September price rise is also worth reading if you want to understand why Lilly made this move and what followed.

Step 3: understand where nume sits, and why we are not the cheapest

We don't compete on price. That's a deliberate decision, not an oversight. What we offer instead is a single transparent charge that covers everything: your free consultation, the prescription, the medicine, free next-working-day tracked delivery by DPD, and access to our clinical team seven days a week for aftercare. Nothing is added later. There is no subscription pulling money from your account between orders; every repeat requires a fresh clinical review, which we carry out as part of the same price.

A named prescriber (a GPhC-registered Independent Prescriber) personally reads every consultation we receive. You can see the clinical team behind that process on our lead prescriber's profile. If you'd like to understand who we are as a service more broadly, our about page covers that. Current treatment pricing is shown on our treatment options page, where you can also start a free consultation.

We recognise that after the September rise, the all-in figure from a service like ours looks larger against some advertised prices. We think that comparison changes when you account for what those other prices exclude.

Step 4: why 'cheapest' is the wrong question for a prescription medicine

Mounjaro is a prescription-only medicine. Its legal supply requires a valid prescription issued after a genuine clinical assessment, and that is not bureaucracy for its own sake. The MHRA has warned publicly about counterfeit weight-loss pens sold online and through social media, some of which have contained insulin rather than the stated active ingredient. In late 2025 enforcement teams raided an illicit UK manufacturing site producing fake tirzepatide pens. The market for medicines sold cheaply with no clinical assessment is not a bargain: it is a safety risk.

Any offer of Mounjaro without a prior clinical assessment, at prices significantly below the market range, or accompanied by discount codes from an unfamiliar seller, should be treated as a red flag. Legitimate private pharmacies are listed on the GPhC register; you can verify any provider there before handing over personal information or payment. Our own GPhC registration number is 9012878, verifiable directly at that link.

For a broader look at what Mounjaro is, how it works, and what treatment through a regulated pharmacy involves, our Mounjaro guide covers the clinical picture fully. If you have questions before you start, our FAQs address the ones we hear most often, and you can always reach our team directly.

For anyone ready to take the next step, the right place to begin is a free consultation: a prescriber reviews your details the same day, and if treatment is clinically suitable, your first pen is on its way the next working day. Check your eligibility here.